The average launch prices for new brand-name drugs and new generic drugs have skyrocketed since 2006, according to an  from 46brooklyn, a drug research firm. Using data from Elsevier's Gold Standard Drug Database and the federal government, the analysis found that the median monthly price of a new brand-name drug increased 381% (from $150 to $722) from 2006-2019 while the median monthly price of a new generic drug increased 712% (from about $100 to almost $800) during that period. The report also found that nearly 80% of all generic drugs studied had no decrease in their average wholesale price in the past five years.

Related News Articles

Headline
The Trump administration today announced steps drug manufacturers must take to lower prescription drug prices in the U.S. to "most favored nation" pricing, the…
Headline
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug…
Headline
The Department of Health and Human Services May 20 announced it has identified specific pricing targets for pharmaceutical manufacturers to meet to satisfy…
Headline
The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation…
Headline
The White House May 12 released an executive order to reduce prescription drug costs by allowing consumers to make direct purchases from drug manufacturers at…
Headline
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription…